Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Corcept Therapeutics Q3 Earnings, Revenue Rise; Shares Fall After Hours

Corcept Therapeutics Q3 Earnings, Revenue Rise; Shares Fall After Hours

MT newswireMT newswire2026/11/03 21:04
05:04 PM EST, 11/03/2026 (MT Newswires) -- Corcept Therapeutics (CORT) reported Q3 earnings late Tuesday of $1.01 per diluted share, up from $0.16 a year earlier. Analysts polled by FactSet expected $0.79. Revenue in the three months ended Sept. 30 rose to $340.5 million from $207.6 million a year earlier. Four analysts projected $336.4 million. The company reiterated 2026 revenue guidance of $1.1 billion to $1.2 billion. Four analysts expect $1.15 billion. Corcept shares fell 2.4% in after-hours trading.
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

Canadian used car dealer UC Automotive (UCAU.RC.US) files for IPO in the US: aims to raise 29 million USD and list on Nasdaq

Canadian used car dealer UC Automotive has applied for a Nasdaq IPO, aiming to raise up to $29 million, with its main focus on the Greater Vancouver market. Kingswood is the sole underwriter.

智通财经•2026/11/09 06:12
Canadian used car dealer UC Automotive (UCAU.RC.US) files for IPO in the US: aims to raise 29 million USD and list on Nasdaq